🚨 Cordis launches one of the largest global DEB registries!. The SELUTION Global Coronary Registry will enroll 10,000 patients worldwide to track real-world outcomes of SELUTION SLR™ DEB for up to 5 years. 📖 Read the full press release here:

Cordis is proud to support the Women in EP Clinical Research Summit at #HRS2025—celebrating women leading the way in EP research & clinical trials. 🗣️ “We’re not just advancing science—we’re redefining it.” – Dr. Nusrath Sultana, Cordis. 👏 Thank you Dr. Patricia Tung & all

🚨 New data from @Cordis:. •3-yr patency of 81.5% & 93.8% freedom from CD-TLR in SELUTION SFA Japan Trial. •SUCCESS Study: 91.1% freedom from CD-TLR at 12 mos in real-world PAD patients. DRUG ELUTION DONE BETTER. Read the full press release here:

Cordis is headed to HRS 2025!. Join us in shaping the future of electrophysiology through a dynamic lineup of events and experiences:. ✅ Visit us at our booth to explore our latest venous closure device.✅ Participate in skills training sessions led by our team of experts.✅

📄 New Case Study Alert!. We’re proud to share a featured case study in EP Lab Digest highlighting the use of the MYNX Control™ Venous Vascular Closure Device (VCD) in pulsed field ablation procedures for atrial fibrillation by Dr. Joseph Bumgarner. Learn how MYNX Control.

🌟 Exciting News! 🌟. Check out the ReliaSeal Study in the @JCardioEP on the novel MYNX CONTROL™ VENOUS Vascular Closure Device (VCD), designed to achieve faster hemostasis without compromising safety. The research highlights the efficiency of vascular closure with the VCD, and

☕ Time for a refill, get your cup and have a #CoffeewithCordis! A series dedicated to hearing from the people who are at the heart of transforming cardiovascular care. Next up, is renowned electrophysiologist, Joseph Bumgarner, MD FACC FHRS. Learn about his musical

☕Grab a cup of coffee and join us as we kick-off a series that highlights the people behind the Cordis mission - to be at the heart of transforming cardiovascular care. On this journey, you'll hear the unique stories of Cordis teammates who go beyond the status quo and health

Attending CRT2025? The Cordis leadership team is looking forward to engaging with YOU. Join us on Sunday, après-CRT, to celebrate a successful conference. RSVP today! #CordisGoBeyond #CRT2025

THANK YOU for an Incredible Western AFib Conference! 🙌. We are grateful for an engaging and insightful Western AFib Conference—thank you to everyone who stopped by our booth and participated in hands-on demonstrations. A special thank you to Dr. Nassir Marrouche and esteemed

🚨Join Cordis at CRT 2025 in Washington, D.C.! 🚨. We’re bringing innovation, hands-on learning, and exclusive networking opportunities to @CRT_meeting 2025, and we can’t wait to connect with you!. ✅ Engage with our team of experts at Booth #303 and the Embassy Learning Center

📢 Join Us for an Exclusive Educational Webinar! 📢. Explore Modern Venous Closure Techniques with renowned electrophysiologist, Dr. @kevinjmakati , as he discusses the role of venous closure, the benefits of extravascular closure & sealants, and the clinical application of the

Seal the Deal in Salt Lake City! . Stop by Booth # 217 to learn about the ReliaSeal clinical study and get a hands-on demo of the MYNX CONTROL™ VENOUS Vascular Closure Device. #CordisGoBeyond #WAFib2025 #Venous #EP

🚀 Empowering Physicians, Advancing Patient Care 🏥. This past weekend, Cordis hosted an incredible Carotid Artery Stenting training at the UCSD Center for the Future of Surgery. “The highest learning for us is when we have difficult cases. We are humbled, we learn.” said Dr.

Improve your facility workflow and enhance patient satisfaction. Contact us to start your MYNX CONTROL™ VENOUS Vascular Closure Device evaluation. This product is not CE marked. #CordisGoBeyond #MoveForwardWithMYNX #Venous #EP

☀️Hollywood, FL in February?! Yes, please! ☀️. We're excited to connect with industry leaders, share cutting-edge insights, and explore the future of endovascular therapy. The exhibit hall opens at 11AM, come by booth 402 and learn more about the Cordis portfolio of peripheral

MYNX CONTROL™ VENOUS Vascular Closure Device is designed to pair procedural simplicity with enhanced safety & reliability. Request more information to connect with your local Cordis representative. This product is not CE marked. #CordisGoBeyond